Tsai John - Insider Non-Derivative Transactions at Blueprint Medicines Corp (BPMC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 17, 2025, Tsai John's relationship to Blueprint Medicines Corp (BPMC) is Director, and currently has 8,742 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BPMC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Tsai John - Insider Non-Derivative Transactions of BPMC Common Stock

Tsai John - Insider Non-Derivative Transactions at BPMC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 18, 2025	U -- (Common Stock)	8742	0	0
Jul 18, 2025	Disposition -- (Common Stock)	3902	0	8742
Jun 19, 2025	Acquisition -- (Common Stock)	3902	128.12	12644
Jun 13, 2024	Acquisition -- (Common Stock)	2242	0	8742
Jun 22, 2023	Acquisition -- (Common Stock)	2600	0	6500
Jan 7, 2023	Acquisition -- (Common Stock)	3900	0	3900